Source link : https://www.newshealth.biz/health-news/promising-findings-for-nipocalimab-in-myasthenia-gravis/
Fixed-dose treatment with nipocalimab, an investigational neonatal Fc receptor blocker, lessened disease severity in generalized myasthenia gravis, according to pivotal phase III data presented at the American Association of Neuromuscular and Electrodiagnostic Medicine annual meeting. In this exclusive MedPage Today video, investigator Tuan Vu, MD, of the University of South Florida in Tampa, discusses the […]
Author : News Health
Publish date : 2024-10-29 17:07:20
Copyright for syndicated content belongs to the linked Source.
inHealth